|BD||Worldwide Vice President, Business Development (M&A), Peripheral Intervention||USA|
In-licensing vs. acquisition: What are Big MedTech’s decision criteria?
Antonio Sanchez-Cordero is the Worldwide Vice President of Business Development (M&A) at Becton Dickinson, Peripheral Intervention. Antonio is a versatile global executive with more than 15 years of experience in the healthcare industry, leading mid-to-large size multinationals in the areas of business development, strategy and M&A.
Formerly, Antonio was the Senior Vice President, Corporate Strategy, Business Development and Licensing at PDI Inc, a global leader in the infection prevention industry, and Vice President, Corporate Development & Strategy at Werfen, a global diagnostics company. Mr Sanchez-Cordero has also experience as an investor, having spent a portion of his career with healthcare-focused private equity funds like Ampersand Capital and Accelmed, as an Operating Partner.
Overall, Antonio is experienced at leveraging inorganic growth to build sustainable businesses in healthcare while further developing the strategy, the capabilities and the innovation pipeline of the organization.
Mr. Sanchez-Cordero completed an MBA from ESADE Business School and Ross School of Business (University of Michigan), and has received a Bachelor’s degree in Law from Pompeu Fabra University (Barcelona, Spain). He regularly participates as a speaker and a panelist in global conferences in the fields of strategy, innovation and corporate development in healthcare.